Nicorette Quickmist (Nicotine)

The nicotine in Nicorette Quickmist binds to nicotinic acetylcholine receptors in the brain, especially in areas that control reward and pleasure. This activation triggers dopamine release, reproducing the pleasurable sensations of smoking while lowering the intensity of withdrawal, thereby helping the user manage cravings during quit attempts.

The appropriate dose of Nicorette Quickmist is set by a qualified healthcare professional. The prescriber evaluates the individual’s smoking history, level of nicotine dependence, and any co‑existing medical conditions before recommending a specific number of sprays per day and a tapering schedule.

Safety data for Nicorette Quickmist in pregnancy or while breastfeeding are limited. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks and benefits with their healthcare provider before using any nicotine replacement therapy.

To request Nicorette Quickmist, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicorette Quickmist delivers nicotine rapidly through the oral mucosa, offering quick relief of cravings, whereas nicotine patches provide a slower, steady release through the skin. The spray allows flexible dosing and can be used on an as‑needed basis, while patches are typically applied once daily and may be less convenient for some users.

Store Nicorette Quickmist at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children and pets to prevent accidental exposure.

Nicorette Quickmist is used by spraying the product onto the inside of the mouth, typically onto the buccal mucosa. The user should follow the prescriber’s instructions regarding the number of sprays per dose and avoid eating or drinking for a short period after administration to ensure optimal absorption.

Serious risks, though uncommon, include allergic reactions such as rash, swelling, or difficulty breathing, as well as cardiovascular events like chest pain or a rapid heart rate. If any of these symptoms occur, the user should stop using the product immediately and seek medical attention.

Nicorette Quickmist should not be used by individuals who are not regular tobacco users, those with known hypersensitivity to nicotine or any excipients in the spray, and patients with severe cardiovascular disease unless advised by a physician. Pregnant or breastfeeding women should only use it after consulting a healthcare professional.